Need the life-sciences signal but short on time?
Get a free quarterly briefing: four pages on what life-sciences operators are actually saying about Biosecure, AI hype vs. substance, and the $50,000 cell-therapy question. Ten minutes, in your inbox.
Tina Valbh, BS Pharm, RPh is a pharmacist with 28 years in life sciences — Managing Partner at Pharma Connect and founder of Tina’s Warriors. She builds patient access programs. Then she got cancer — and discovered none of it worked the way the slide decks said.
Karla Loken, DO, OBGYN, FACOOG practiced OB-GYN for 20+ years before leading clinical development and medical affairs roles at Hologic, Roche, HerMD, and FEMSelect. She was diagnosed with appendix cancer 3 months ago. She’s navigating the system she helped build.
In Today’s Episode We Discuss:
Get a free quarterly briefing: four pages on what life-sciences operators are actually saying about Biosecure, AI hype vs. substance, and the $50,000 cell-therapy question. Ten minutes, in your inbox.
Free briefing
Four pages, ten minutes: the Biosecure Act, AI hype vs. substance, and the $50,000 cell-therapy question. Drop your email and it is in your inbox.
No spam. Unsubscribe anytime.
Check your inbox.
Your briefing is on its way.
